<DOC>
	<DOCNO>NCT00229060</DOCNO>
	<brief_summary>The purpose study compare clinical response rate doripenem versus comparator treatment hospitalize patient complicate intra-abdominal infection .</brief_summary>
	<brief_title>Doripenem Treatment Complicated Intra-Abdominal Infections</brief_title>
	<detailed_description>Doripenem antibiotic medication yet approve US FDA . This phase 3 , multicenter , prospective , randomize , double-blind study doripenem versus comparator antibiotic ass effectiveness safety doripenem treatment complicate intra-abdominal infection hospitalize adult . Doripenem comparator administer . The primary endpoint clinical response measure late follow-up visit . The patient receive either doripenem comparator ; treatment duration 5 14 day .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Appendicitis</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<criteria>Has requirement surgical intervention within 24 hour study entry Requirement antibacterial therapy addition surgical intervention certain intraabdominal infection Female patient pregnant , nursing , child bear potential use medically accept , effective method birth control Any rapidlyprogressing disease immediately lifethreatening illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Complicated Intra-Abdominal Infections</keyword>
	<keyword>Appendicitis</keyword>
	<keyword>Cholecystitis</keyword>
	<keyword>Peritonitis</keyword>
</DOC>